000			01450 a2200409 4500
005			20250516151404.0
264		0	_c20141028
008			201410s 0 0 eng d
022			_a1463-1326
024	7		_a10.1111/dom.12117 _2doi
040			_aNLM _beng _cNLM
100	1		_aHerring, R
245	0	0	_aHepatoselectivity and the evolution of insulin. _h[electronic resource]
260			_bDiabetes, obesity & metabolism _cJan 2014
300			_a1-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAnimals
650	0	4	_aBiological Evolution
650	0	4	_aClinical Trials as Topic
650	0	4	_aDiabetes Mellitus, Type 1 _xdrug therapy
650	0	4	_aDiabetic Angiopathies _xprevention & control
650	0	4	_aHepatocytes _xdrug effects
650	0	4	_aHumans
650	0	4	_aHypoglycemia _xchemically induced
650	0	4	_aHypoglycemic Agents _xadverse effects
650	0	4	_aInsulin _xanalogs & derivatives
650	0	4	_aInsulin, Long-Acting _xadministration & dosage
650	0	4	_aLiver _xdrug effects
650	0	4	_aMolecular Structure
650	0	4	_aPancreas _xmetabolism
650	0	4	_aPortal System _xmetabolism
650	0	4	_aWeight Gain
700	1		_aJones, R H
700	1		_aRussell-Jones, D L
773	0		_tDiabetes, obesity & metabolism _gvol. 16 _gno. 1 _gp. 1-8
856	4	0	_uhttps://doi.org/10.1111/dom.12117 _zAvailable from publisher's website
999			_c22756075 _d22756075